Monographie - Thiopental sodium

Senaste uppdateringen :
19/11/2024

Thiopental sodium

Molekylstruktur

Varunamn

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

Anapental	Egypten
Anental	Colombia, Venezuela
Epental	Saudi-Arabien
Exipental	Iran
Farmotal	Italien
Gabapentax	Colombia
Hipnopento	Argentina
Nesdonal	Nederländerna
Pantul	Ecuador, Peru
Pensodital	Mexiko
Pental	Turkiet
Pentarim	Mexiko
Pentax	Venezuela
Pentocur	Island, Norge
Pentotex	Malaysia
Pentothal	Australien, Belgien, Danmark, Finland, Grekland, Italien, Kanada, Luxemburg, Mexiko, Schweiz, Sverige
Sodipental	Colombia, Mexiko
Thiojex	Chile
Thiomek	Peru
Thiopental	Egypten, Frankrike, Grekland, Iran, Irland, Malaysia, Marocko, Österrike, Polen, Rumänien, Saudi-Arabien, Storbritannien, Tunisien, Tyskland, Ungern
Thiopentax	Ecuador, Venezuela
Tiobarbital	Colombia, Spanien
Trapanal	Tyskland
Zedisol	Mexiko

Hänvisningar : Thiopental sodium

	Typ	Publikation
59	tidningen	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
125	tidningen	Chernin EL, Stewart JT, Smiler B. Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C. Am J Health-Syst Pharm 1996 ; 53: 1576-1579.
126	tidningen	Prankerd RJ, Jones RD. Physicochemical compatibility of propofol with thiopental sodium. Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
299	tidningen	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
314	tidningen	Chiu MF, Schwartz ML. Visual compatibility of injectable drugs used in the intensive care unit. Am J Health-Syst Pharm 1997 ; 54: 64-65.
319	tidningen	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
350	tidningen	Martens HJ, De Goede PN, Van Loenen AC. Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers. Am J Hosp Pharm 1990 ; 47: 369-373.
527	tidningen	Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR. Chemical stability of thiopental sodium injection in disposable plastic syringes. J Clin Pharm Ther 1987 ; 12: 339-342.
642	tidningen	Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA. Norepinephrine stability in saline solutions. Hosp Pharm 1988 ; 23: 44,49, 59.
755	Laboratorium	Pancuronium (Pavulon®) - Résumé des caractéristiques du produit MSD France 2016
871	tidningen	Haws JL, Herman N, Clark Y, Bjoraker R, Jones D. The chemical stability and sterility of sodium thiopental after preparation. Anesth Analg 1998 ; 86: 208-213.
919	tidningen	Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS. Propofol and thiopental in a 1:1 volume mixture is chemically stable. Anesth Analg 1998 ; 86: 422-426.
1173	tidningen	Kowaluk EA, Roberts MS, Blackburn HD, Polack AE. Interactions between drugs and polyvinyl chloride infusion bags. Am J Hosp Pharm 1981 ; 38: 1308-1314.
1713	tidningen	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	tidningen	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1803	tidningen	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
2073	tidningen	Taniguchi T, Yamamoto K, Kobayashi T. Precipitate formed by thiopentone and vecuronium causes pulmonary embolism. Can J Anesth 1998 ; 45: 347-351.
2079	tidningen	Morton WD, Lerman J. The effect of pancuronium on the solubility of aqueous thiopentone. Can J Anesth 1987 ; 34: 87-89.
2090	tidningen	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2105	tidningen	Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C. Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo. Farm Hosp 1999 ; 23: 357-360.
2146	tidningen	Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers. Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
2231	tidningen	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3134	tidningen	Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM. Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua. Enferm Intensiva 2010 ; 21: 96-103.
3212	tidningen	Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M. Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos. Enferm Intensiva 2011 ;22:78-82.
3372	tidningen	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3373	tidningen	Khan S, Stannard N, Greijn J. Precipitation of thiopental with muscle relaxants: a potential hazard. J R Soc Med Sh Rep 2011 ; 2: 58.
3377	tidningen	Huddy NC, Durcan JJ. Precipitation betwen meptazinol and thiopentone. Anaesthesia 1983 ; 38: 601-602.
3408	tidningen	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3464	tidningen	Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau. Compatibilidad física de la amiodarona en perfusión continua Enferm Clin 2011 21:25-29.
3466	tidningen	B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau. Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos Enferm Intensiva 2011 ;22:78-82.
3501	Laboratorium	Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics Pfizer 2011
3503	Laboratorium	Fentanyl - Summary of product Characteristics Hameln Pharmaceuticals 2012
3525	Laboratorium	Pethidine hydrochloride - Summary of product Characteristics AMCO Amdipharm Mercury 2012
3526	Laboratorium	Clindamycin (Dalacin®) - Summary of Product Characteristics Pharmacia 2010
3531	Laboratorium	Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics Wockhardt 2014
3549	Laboratorium	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3564	Laboratorium	Rocuronium B Braun - Résumé des caractéristiques du produit. B Braun 2012
3599	Laboratorium	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3600	Laboratorium	Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit UCB Pharma SA 2009
3601	Laboratorium	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012
3607	Laboratorium	Esmolol hydrochloride for injection - Summary of Product Characteristics AOP Orphan Pharmaceuticals AG 2013
3612	Laboratorium	Doxapram (Dopram) - Summary of Product Characteristics Amdipharm Mercury Company 2012
3614	Laboratorium	Nicardipine Injection - Summary of Product Characteristics American Regent Inc 2013
3629	Laboratorium	Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics Actavis UK 2014
3630	Laboratorium	Vecuronium (Norcuron®) - Summary of Product Characteristics Merck Sharp Dohme 2012
3631	Laboratorium	Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit Aguettant 2016
3674	Laboratorium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3675	Laboratorium	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3676	Laboratorium	Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit Hospira 2014
3767	tidningen	Legris M.E, Lavoie A, Forrest J.M, Hildgen P. Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 2014 ; 47, 3 : 167-172.
3823	tidningen	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3932	Laboratorium	Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit Serb Laboratoire 2015
3941	Laboratorium	Nicardipine - Summary of Product Characteristics Concordia International 2017
4009	Laboratorium	Droperidol - Résumé des Caractéristiques du Produit Panpharma 2017
4428	tidningen	Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
4700	Laboratorium	Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics AS Kalceks 2022

Mentions Légales